Aged chimpanzees exhibit pathologic hallmarks of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) is a uniquely human brain disorder characterized by the accumulation of amyloid beta protein (Aβ) into extracellular plaques, neurofibrillary tangles (NFT) made from intracellular, abnormally phosphorylated tau, and selective neuronal loss. We analyzed a large group of aged chimpanzees (n = 20, ages 37–62 years) for evidence of Aβ and tau lesions in brain regions affected by AD in humans. Aβ was observed in plaques and blood vessels, and tau lesions were found in the form of pretangles, NFT, and tauimmunoreactive neuritic clusters. Aβ deposition was higher in vessels than in plaques and correlated with increases in tau lesions, suggesting that amyloid build-up in the brain’s microvasculature precedes plaque formation in chimpanzees. Age was correlated to greater volumes of Aβ plaques and vessels. Tangle pathology was observed in individuals that exhibited plaques and moderate or severe cerebral amyloid angiopathy, a condition in which amyloid accumulates in the brain’s vasculature. Amyloid and tau pathology in aged chimpanzees suggests these AD lesions are not specific to the human brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 3×
“…a pathology score was computed utilizing a 209 system adapted from staging guidelines for Aβ and NFT deposition in AD and CAA (Table 2) (Attems et al., 210 2007; Braak et al., 2006; Braak and Braak, 1991; Mirra et al., 1991; Montine et al., 2012; Thal et al., 2002; 211 Vonsattel et al., 1991).”
BackgroundMethodNeuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 2×
“453 Approximately 80% of AD patients show Aβ accumulation in the brain’s microvasculature (i.e., CAA) in 454 addition to plaques (Serrano-Pozo et al., 2011).”
BackgroundBraak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · cited 4×
“…scoring system based on 86 clinical staging parameters for Aβ and NFT deposition in humans (see Pathology Identification and Scoring) 87 (Attems et al., 2007; Braak et al., 2006; Braak and Braak, 1991; Mirra et al., 1991; Montine et al., 2012; Thal 88 et al., 2002; Vonsattel et al., 1991).”
BackgroundMethodInfluentialMontine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894 · cited 6×
“…scoring system based on 86 clinical staging parameters for Aβ and NFT deposition in humans (see Pathology Identification and Scoring) 87 (Attems et al., 2007; Braak et al., 2006; Braak and Braak, 1991; Mirra et al., 1991; Montine et al., 2012; Thal 88 et al., 2002; Vonsattel et al., 1991).”
BackgroundMethodInfluentialInitial sequence of the chimpanzee genome and comparison with the human genome
The Chimpanzee Sequencing and Analysis Consortium (2005) · Nature · doi:10.1038/nature04072 · Cited by 2,459
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 1×
“In AD, neuron densities in layer II of the EC are decreased substantially compared to 501 non-demented controls between the ages of 60 and 90 (Gómez-Isla et al., 1996).”
ResultRelationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940
Fjell, A. M., McEvoy, L., Holland, D., Dale, A. M., & Walhovd, K. B. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.004 · Cited by 799 · cited 1×
“Whether amyloid pathology is part of the normal aging process in 522 humans is a continuing debate (Arriagada et al., 1992; Fjell et al., 2014).”
BackgroundAmyloid β Protein (Aβ) in Alzheimeri's Disease Brain
Gravina, S. A., Ho, L., Eckman, C. B., Long, K. E., Otvos, L., Younkin, L. H., Suzuki, N., & Younkin, S. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7013 · Cited by 676
Animal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676 · cited 1×
“Moreover, amyloid 71 precursor protein 695 (APP695) is more than 99% identical in chimpanzees and humans and can be 72 cleaved into Aβ 40/42 peptides with 100% sequence homology to humans (Cervenáková et al., 1994; 73 Götz and Ittner, 2008; Heuer et al., 2012).”
BackgroundCerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study
Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Nelson, P. T., Braak, H., & Markesbery, W. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181919a48 · Cited by 643 · cited 1×
“69 Chimpanzees share 100% sequence homology and all six tau isoforms with humans (Chimpanzee 70 Sequencing and Analysis Consortium, 2005; Holzer et al., 2004; Nelson et al., 2009).”
BackgroundArriagada, P. V., Marzloff, K., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.9.1681 · Cited by 638
Hof, P. R., Morrison, J. H., & Cox, K. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.903010105 · Cited by 365 · cited 2×
“…and V of the neocortex and stratum pyramidale in the hippocampus display extensive 131 neuron and synapse loss, and the distribution of neuritic Aβ plaques and NFT is most prevalent in these 132 cortical layers (Akram et al., 2008; Bussière et al., 2003; Hof et al., 1990; Scheff and Price, 2006).”
BackgroundResultSelf-citationAmyloid Angiopathy–Related Vascular Cognitive Impairment
Greenberg, S. M., Gurol, M. E., Rosand, J., & Smith, E. E. (2004) · Stroke · doi:10.1161/01.str.0000143224.36527.44 · Cited by 298
Alzheimer’s disease-related alterations in synaptic density: neocortex and hippocampus.
Scheff, S. W., & Price, D. A. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s312 · Cited by 284
Vascular pathologies and cognition in a population-based cohort of elderly people
Fernando, M. S., & Ince, P. G. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.004 · Cited by 239 · cited 1×
“468 CAA is more severe in demented patients and is an independent risk factor for cognitive decline (Attems 469 et al., 2007; Fernando and Ince, 2004; Greenberg et al., 2004; Nicoll et al., 2004; Serrano-Pozo et al., 2011; 470 Tian et al., 2004; Xu et al., 2003; Zekry et al., 2003).”
BackgroundLemere, C. A., Beierschmitt, A., Iglesias, M., Spooner, E. T., Bloom, J. K., Leverone, J. F., Zheng, J. B., Seabrook, T. J., Louard, D., Li, D., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63296-8 · Cited by 230
Bussière, T., Giannakopoulos, P., Bouras, C., Perl, D. P., Morrison, J. H., & Hof, P. R. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10760 · Cited by 185 · cited 1×
“…and V of the neocortex and stratum pyramidale in the hippocampus display extensive 131 neuron and synapse loss, and the distribution of neuritic Aβ plaques and NFT is most prevalent in these 132 cortical layers (Akram et al., 2008; Bussière et al., 2003; Hof et al., 1990; Scheff and Price, 2006).”
BackgroundSelf-citationNeuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease.
Gearing, M., Rebeck, G. W., Hyman, B. T., Tigges, J., & Mirra, S. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9382 · Cited by 179 · cited 3×
“Several pathological examinations of the chimpanzee (Pan troglodytes) and 61 orangutan (Pongo pygmaeus) brain revealed diffuse Aβ plaques and vascular amyloid, but not tau-62 positive NFT and neuropil threads (Gearing et al., 1997, 1996, 1994).”
BackgroundMethodResultNonhuman Primate Models of Alzheimer-Like Cerebral Proteopathy
Heuer, E., F. Rosen, R., Cintron, A., & C. Walker, L. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799315885 · Cited by 169
β-Amyloid (Aβ) Deposition in the Brains of Aged Orangutans
Gearing, M., Tigges, J., Mori, H., & Mirra, S. S. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00012-2 · Cited by 130 · cited 3×
“Previous studies in aged monkeys and great apes confirmed the 51 presence of diffuse and neuritic amyloid plaques as well as vascular amyloid (Gearing et al., 1997, 1996, 52 1994; Geula et al., 2002; Heuer et al., 2012; Kimura et al., 2003; Lemere et al., 2008, 2004; Martin et al., 53 1991; E J…”
BackgroundResultBussire, T., Gold, G., Kvari, E., Giannakopoulos, P., Bouras, C., Perl, D. P., Morrison, J. H., & Hof, P. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00942-9 · Cited by 122
Self-citationPreserved Number of Entorhinal Cortex Layer II Neurons in Aged Macaque Monkeys
Gazzaley, A. H., Thakker, M. M., Hof, P. R., & Morrison, J. H. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00112-7 · Cited by 122
Self-citationAge-related cognitive deficits in rhesus monkeys mirror human deficits on an automated test battery
Nagahara, A. H., Bernot, T., & Tuszynski, M. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.007 · Cited by 110
Perez, S. E., Raghanti, M. A., Hof, P. R., Kramer, L., Ikonomovic, M. D., Lacor, P. N., Erwin, J. M., Sherwood, C. C., & Mufson, E. J. (2013) · Journal of Comparative Neurology · doi:10.1002/cne.23428 · Cited by 95 · cited 4×
“…amyloid (Gearing et al., 1997, 1996, 52 1994; Geula et al., 2002; Heuer et al., 2012; Kimura et al., 2003; Lemere et al., 2008, 2004; Martin et al., 53 1991; E J Mufson et al., 1994; Oikawa et al., 2010; Perez et al., 2016, 2013; Poduri et al., 1994; Rosen et 54 al., 2008; Walker et al., 1987).”
BackgroundResultInfluentialSelf-citationSenile plaques in aged squirrel monkeys
Walker, L. C., Kitt, C. A., Schwam, E., Buckwald, B., Garcia, F., Sepinwall, J., & Price, D. L. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90067-4 · Cited by 94
Neuritic and Diffuse Plaque Associations with Memory in Non-Cognitively Impaired Elderly
Malek-Ahmadi, M., Perez, S. E., Chen, K., & Mufson, E. J. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160365 · Cited by 73 · cited 1×
“While diffuse 433 plaques are observed in cognitively intact elderly people, neuritic plaques with dense cores are associated 434 with cognitive impairment and AD-related dementia (Arriagada et al., 1992; Malek-Ahmadi et al., 2016).”
BackgroundSelf-citationCommentary: is Alzheimer's disease uniquely human?
Finch, C. E., & Austad, S. N. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.025 · Cited by 72 · cited 1×
“DISCUSSION 423 To date, less than 50 brains of aged apes have been examined for AD pathology across all prior 424 studies (Finch and Austad, 2015).”
BackgroundPerez, S. E., Sherwood, C. C., Cranfield, M. R., Erwin, J. M., Mudakikwa, A., Hof, P. R., & Mufson, E. J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.017 · Cited by 50
Self-citationRaghanti, M. A., Spocter, M. A., Stimpson, C. D., Erwin, J. M., Bonar, C. J., Allman, J. M., Hof, P. R., & Sherwood, C. C. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.058 · Cited by 42 · cited 2×
“…of 136 antibodies and epitopes in Table S2) following previously established protocols utilizing the avidin-biotin-137 peroxidase method and either 3,3’-diaminobenzidine (DAB) with nickel enhancement or Vector NovaRED 138 (SK-4100/SK-4800, Vector Laboratories) (Raghanti et al., 2009, 2008).”
MethodSelf-citation
Cited by
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease
Arnsten, A. F. T., Datta, D., Del Tredici, K., & Braak, H. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12192 · Cited by 361
Franjic, D., Skarica, M., Ma, S., Arellano, J. I., Tebbenkamp, A. T. N., Choi, J., Xu, C., Li, Q., Morozov, Y. M., Andrijevic, D., et al. (2022) · Neuron · doi:10.1016/j.neuron.2021.10.036 · Cited by 308
“Importantly, our results suggest that these functional interactions in a subset of ExNs and astrocytes seem to be phylogenetically specific to OldWorldmonkeys and apes (parvorder Catarrhini), species that show more marked signs of pathology related to aging, such as AD, than other species (Perez et al., 2013; Finch an…”
New mechanism of nerve injury in Alzheimer’s disease: β‐amyloid‐induced neuronal pyroptosis
Han, C., Yang, Y., Guan, Q., Zhang, X., Shen, H., Sheng, Y., Wang, J., Zhou, X., Li, W., Guo, L., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15439 · Cited by 193
Microglia in Aging and Alzheimer’s Disease: A Comparative Species Review
Edler, M. K., Mhatre-Winters, I., & Richardson, J. R. (2021) · Cells · doi:10.3390/cells10051138 · Cited by 126
“Dystrophic microglia have been noted in neocortical layers I and II of elderly chimpanzees (37–62 years), though age was not associated with changes in activated microglia morphology [38].”
BackgroundSelf-citation
Metadata
- Authors
- Edler, M. K., Sherwood, C. C., Meindl, R. S., Hopkins, W. D., Ely, J. J., Erwin, J. M., Mufson, E. J., Hof, P. R., & Raghanti, M. A.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 59
- Pages
- 107-120
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2741997618
- Cited by
- 133
- References
- 35
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.